Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Binmei Biotechnology is a China-based biotechnology and ingredient manufacturer focused on natural functional ingredients and colorants, especially spirulina-derived phycocyanin and related extracts. The company develops, manufactures, and exports products used across food, dietary supplement, cosmetic, and some pharmaceutical-related applications. Its portfolio includes multiple grades of phycocyanin, spirulina juice, spirulina extracts, butterfly pea flower extract, safflower yellow, rose juice, aronia products, and cuttlefish ink ingredients. Binmei positions itself as a natural ingredient and application-solutions provider rather than a therapeutic drug developer, with in-house R&D, testing capabilities, and certified production operations. The business appears commercially active with international sales and a customer base spanning dozens of countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Binmei Biotechnology.